206 related articles for article (PubMed ID: 9820497)
1. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
[TBL] [Abstract][Full Text] [Related]
2. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines.
Crotzer VL; Christian RE; Brooks JM; Shabanowitz J; Settlage RE; Marto JA; White FM; Rickinson AB; Hunt DF; Engelhard VH
J Immunol; 2000 Jun; 164(12):6120-9. PubMed ID: 10843661
[TBL] [Abstract][Full Text] [Related]
3. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
[TBL] [Abstract][Full Text] [Related]
4. Peptide presentation to an alloreactive CTL clone is modulated through multiple mechanisms involving polymorphic and conserved residues in HLA-B27.
García-Peydró M; Paradela A; Lamas JR; López De Castro JA
J Immunol; 1999 Dec; 163(11):6060-4. PubMed ID: 10570294
[TBL] [Abstract][Full Text] [Related]
5. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
[TBL] [Abstract][Full Text] [Related]
6. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
García-Peydró M; Martí M; López de Castro JA
J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
[TBL] [Abstract][Full Text] [Related]
7. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length.
Green KJ; Miles JJ; Tellam J; van Zuylen WJ; Connolly G; Burrows SR
Eur J Immunol; 2004 Sep; 34(9):2510-9. PubMed ID: 15307183
[TBL] [Abstract][Full Text] [Related]
8. Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.
Levitsky V; Zhang QJ; Levitskaya J; Kurilla MG; Masucci MG
J Immunol; 1997 Dec; 159(11):5383-90. PubMed ID: 9548478
[TBL] [Abstract][Full Text] [Related]
9. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.
Lee SP; Tierney RJ; Thomas WA; Brooks JM; Rickinson AB
J Immunol; 1997 Apr; 158(7):3325-34. PubMed ID: 9120290
[TBL] [Abstract][Full Text] [Related]
10. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
Turcanová V; Höllsberg P
J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
[TBL] [Abstract][Full Text] [Related]
11. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.
Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA
J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027
[TBL] [Abstract][Full Text] [Related]
12. A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance.
Reali E; Guerrini R; Marastoni M; Tomatis R; Masucci MG; Traniello S; Gavioli R
J Immunol; 1999 Jan; 162(1):106-13. PubMed ID: 9886375
[TBL] [Abstract][Full Text] [Related]
13. The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity.
Paradela A; García-Peydró M; Vázquez J; Rognan D; López de Castro JA
J Immunol; 1998 Nov; 161(10):5481-90. PubMed ID: 9820524
[TBL] [Abstract][Full Text] [Related]
14. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
Villadangos JA; Galocha B; López de Castro JA
J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
[TBL] [Abstract][Full Text] [Related]
15. Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27.
Lamas JR; Brooks JM; Galocha B; Rickinson AB; López de Castro JA
Int Immunol; 1998 Mar; 10(3):259-66. PubMed ID: 9576613
[TBL] [Abstract][Full Text] [Related]
16. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis.
Gómez P; Montserrat V; Marcilla M; Paradela A; de Castro JA
Eur J Immunol; 2006 Jul; 36(7):1867-81. PubMed ID: 16783853
[TBL] [Abstract][Full Text] [Related]
17. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
[TBL] [Abstract][Full Text] [Related]
18. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
19. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity.
López D; Rojo S; Calvo V; López de Castro JA
J Immunol; 1992 Feb; 148(4):996-1002. PubMed ID: 1371137
[TBL] [Abstract][Full Text] [Related]
20. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
Calvo V; Rojo S; López D; Galocha B; López de Castro JA
J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]